WHERE DOES THE MONEY GO?

MORE PRECISE RISK ESTIMATES FOR EARLY-STAGE BREAST CANCER

2021 - 2023

INSTITUTION:

CHIEF RESEARCHER:

The University of Melbourne/Peter MacCallum Cancer Centre

Dr. Peter Savas

This research will study how different changes in the DNA in the tumours of over 11,000 patients affect the chance of the cancer coming back after surgery.

When a patient’s cancer is curable, a big part of the treatment is determined by estimating the risk that the cancer will come back. Accurate risk estimation is important, because patients at higher risk of recurrence require a more intensive, and ideally more tailored treatment. More information is required to understand what makes a particular cancer higher risk, and if there are better treatments for these higher risk cancers. Artificial intelligence techniques will be used to generate digital footprints of the tumour and to teach computers to understand microscope pictures. In other words this will allow computers to 'see' things which a human pathologist could miss and thereby improve risk estimates and provide patients with the best care for their situation.

The University of Melbourne/Peter MacCallum Cancer Centre
The University of Melbourne/Peter MacCallum Cancer Centre
MORE PRECISE RISK ESTIMATES FOR EARLY-STAGE BREAST CANCER